Adverse event reporting in the recent study by Imanaka et al. describing the efficacy and safety of tapentadol extended release for tumor-related pain

Curr Med Res Opin. 2014 Sep;30(9):1909-10. doi: 10.1185/03007995.2014.919909. Epub 2014 May 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chronic Pain / drug therapy*
  • Female
  • Humans
  • Male
  • Neoplasms*
  • Pain Management / methods*
  • Phenols / administration & dosage*
  • Phenols / adverse effects*

Substances

  • Phenols